Moffitt logo

Articles related to Clinical Trials

Magrolimab Plus Azacitidine Results in Promising Activity in Higher-Risk MDS Patients

Phase 1b trial results show the combo therapy has manageable toxicity and encouraging responses for patients, including those with difficult to treat p53 mutations Read More

Moffitt Receives $3.7 Million Grant to Increase Minority Accrual to Cancer Treatment Trials

Multi-level approach will leverage digital tools and community outreach to increase education on trials and enrollment Read More

Clinical Trial Consent

How Do Cancer Clinical Trials Work?

Clinical trials are essential to advancing the standard of care for current and future cancer patients. How do these research studies work? Find out here. Read More

Mistys Story TIL Therapy

Cervical Cancer Patient Grateful for Immunotherapy Clinical Trial

Misty, who had a rare type of cervical cancer, found hope after enrolling in a clinical trial involving tumor-infiltrating lymphocyte (TIL) therapy. Read More

New Study Highlights CAR T-cell Therapy Success for Lymphoma When Used as Standard of Care

Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data Read More

Immune-Activating Drug Combination is Safe and Effective in Melanoma Patients with Brain Metastases

Ipilimumab plus nivolumab results in quick, durable responses and a manageable safety profile in patients with metastatic melanoma in the brain Read More